花王ブローネポイントカバー ナチュラルブラック 7.5ml 48個セット Kao

Press Release
Ziemer Ophthalmic Systems AG to present its FEMTO LDV Z8 device
with full cataract capabilities
FOR IMMEDIATE RELEASE
Company
Contact person
Phone
e-mail
Web
Ziemer Ophthalmic Systems AG
Sandro Palumbo, Vice President Marketing
+41 32 332 70 52
sandro.palumbo@ziemergroup.com
www.ziemergroup.com / www.femtoldv.com
Key information
• Ziemer to present the FEMTO LDV Z8 with full cataract capabilities at the upcoming
ESCRS congress in Amsterdam
1
• The FEMTO LDV Z8 is designed for cornea, presbyopia and cataract procedures
• The FEMTO LDV Z8 is a small, portable device, which is designed to be easily introduced
into the surgeon’s workflow
Port, Switzerland, October 2, 2013
Ziemer Ophthalmic Systems AG is pleased to present at the upcoming ESCRS congress in
Amsterdam the latest product in its femtosecond laser line FEMTO LDV Z Models – the Z8. The
FEMTO LDV Z8 will be able to perform a large variety of cornea, presbyopia and also cataract
1
procedures . The power of one: truly a unique variety of applications in one femtosecond laser.
Very low energy combined with a high repetition rate has proven to provide superior outcomes in
2
corneal and presbyopia applications . This unique LDV laser technology is now fully incorporated in
the FEMTO LDV Z8 device, providing gentle clear corneal and arcuate incisions, a precise
capsulotomy and lens fragmentation. A new 2 in 1 liquid patient interface supports an excellent
laser transmission and a low intraocular pressure is achieved. Its portability and compact design
allows for an easy integration in the surgeon’s workflow.
First clinical results will be shown during the ESCRS lunch symposium on Saturday, October 5,
13.00 – 14.00h in the meeting room G102/103 at the RAI congress center in Amsterdam.
The FEMTO LDV Z8 is pending CE mark and FDA approval. FEMTO LDV Z2, Z4, Z6 and soon Z81–
are powerful models for treating a broad variety of applications in ocular surgery. The concept
embraces a strategy that grows with the surgeon’s practice, offering the latest technology available
today, on a platform that is ready for tomorrow. A seamless and stepwise upgrade between the
different systems can be performed at any time.
For further information about the FEMTO LDV Z Models please visit our dedicated website:
www.femtoldv.com or come to see us at the booth.
1
The creation of a corneal pocket is part of a presbyopia intervention. Availability of related corneal inlays and implants according to policy of
the individual manufacturers and regulatory status in the individual countries. Cataract procedures with the FEMTO LDV Z2, Z4, Z6 and Z8
models are not cleared in the United States and in all other countries.
2
Data on file at Ziemer Ophthalmic Systems AG
Press Release_Announcement of FEMTO LDV Z8 - Cataract_FINAL.docx / 13-10-03 / 1
Ziemer Ophthalmic Systems AG
Allmendstrasse 11 / CH-2562 Port, Switzerland / PHONE: +41 32 332 7050 / FAX: +41 32 332 7071
About Ziemer:
Ziemer Ophthalmic Systems AG, a Ziemer Group Company, is a privately held company incorporated in Port, Switzerland. Founded in 1998, Ziemer Group is focused on developing, manufacturing, and marketing leading edge diagnostic and surgical ophthalmic products. Successful
products developed by the group include the FEMTO LDV™ and FEMTO LDV™ Crystal Line and
FEMTO LDV Z Models Femtosecond Surgical Lasers, the AMADEUS® Microkeratome, the
PASCAL® Dynamic Contour Tonometer and the GALILEI™ and GALILEI™ G4 and G6 Dual
Scheimpflug Analyzers.
Ziemer USA, Inc. and Ziemer Ophthalmology Deutschland GmbH are fully owned subsidiaries of
Ziemer Group
The FEMTO LDV™ Z Models are marketed and distributed by Ziemer Ophthalmic Systems AG and
its worldwide network of authorized distributors.
GALILEI™, FEMTO LDV™ are trademarks, and PASCAL®, AMADEUS® and Z-LASIK® are
registered trademarks of Ziemer Group Companies.
Press Release_Announcement of FEMTO LDV Z8 - Cataract_FINAL.docx / 13-10-03 / 2
Ziemer Ophthalmic Systems AG
Allmendstrasse 11 / CH-2562 Port, Switzerland / PHONE: +41 32 332 7050 / FAX: +41 32 332 7071